A Seamless Phase IIa/IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial to Evaluate the Efficacy and Safety of MK-7622 as an Adjuncitve Therapy to Donepezil for Symptomatic Treatment in Subjects with Alzheimer’s Disease

The PI of this project was:

This project was funded by: Merck

The term of this project was: September 2014 to October 2017

The number of subjects scanned during this project was: 10